secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001323885-25-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure Q4 revenue $124.3M (+16.6% YoY); guides FY25 rev $517-527M
-------------------------------------------------------------------

- Q4 revenue $124.3M (+16.6%); full year revenue $465.3M (+16.5%).
- Q4 GAAP net loss $0.33/sh; adj. loss $0.08/sh; adj. EBITDA positive $12.7M.
- Full year 2024 adj. EBITDA $31.1M (vs $19.4M in 2023); adj. loss $0.67/sh (vs $0.75).
- Launched cryoSPHERE+, cryoSPHERE MAX, AtriClip FLEX-Mini in US, EnCompass clamp in Europe.
- FY2025 guidance: rev $517-527M; adj. EBITDA $42-44M; adj. loss $0.57-0.64/sh.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000005/0001323885-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000005/atrc-20250212.htm
  HTML page:      https://secwatch.observer/filing/0001323885-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer